CC
BEAT

Cannell Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Cannell Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-204,594
Closed -$9.32M – 69
2020
Q3 		$9.32M Buy
+204,594
New +$8.55M 3.41% 12
2018
Q3 		– Sell
-171,762
Closed -$7.73M – 67
2018
Q2 		$7.73M Sell
171,762
-138,969
-45% -$5.54M 1.98% 18
2018
Q1 		$9.65M Sell
310,731
-227,113
-42% -$7.47M 3.1% 11
2017
Q4 		$16.1M Buy
537,844
+79,661
+17% +$2.31M 4.68% 5
2017
Q3 		$15.1M Sell
458,183
-224,793
-33% -$7.79M 4.44% 5
2017
Q2 		$22.8M Sell
682,976
-228,803
-25% -$6.83M 6.52% 3
2017
Q1 		$26.4M Sell
911,779
-3,781
-0.4% -$93.7K 8.37% 1
2016
Q4 		$20.5M Sell
915,560
-65,404
-7% -$1.28M 6.53% 5
2016
Q3 		$18.2M Sell
980,964
-419,511
-30% -$7.91M 7.24% 1
2016
Q2 		$22.8M Sell
1,400,475
-157,273
-10% -$2.31M 9.28% 1
2016
Q1 		$18.2M Buy
1,557,748
+77,425
+5% +$865K 7.64% 2
2015
Q4 		$17.3M Sell
1,480,323
-9,451
-0.6% -$120K 7.27% 3
2015
Q3 		$18.2M Sell
1,489,774
-35,445
-2% -$452K 6.84% 2
2015
Q2 		$14.4M Buy
1,525,219
+70,437
+5% +$652K 4.7% 3
2015
Q1 		$12.9M Hold
1,454,782
– – 4.03% 5
2014
Q4 		$14.6M Buy
1,454,782
+58,696
+4% +$503K 4.82% 4
2014
Q3 		$9.37M Buy
1,396,086
+607,895
+77% +$4.26M 3.52% 8
2014
Q2 		$5.65M Buy
788,191
+335,897
+74% +$2.67M 1.96% 22
2014
Q1 		$4.56M Buy
452,294
+238,212
+111% +$2.19M 1.63% 26
2013
Q4 		$1.7M Buy
+214,082
New +$2M 0.69% 38
2013
Q3 		– Sell
-420,220
Closed -$2.48M – 85
2013
Q2 		$2.48M Buy
+420,220
New +$1.41M 1.47% 28

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Cannell Capital's BEAT Position: Q4 2020 in Review

Cannell Capital sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 204,594 shares — an estimated $9.32M sold.

Cannell Capital first reported a position in BEAT in Q2 2013 and held it in 21 quarters. The position peaked at $26.4M in Q1 2017. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Cannell Capital reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Cannell Capital sold 204,594 BioTelemetry, Inc. shares in Q4 2020, an estimated $9.32M.
  • Cannell Capital first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 21 quarters.
  • Cannell Capital's BioTelemetry, Inc. position peaked at $26.4M in Q1 2017.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Cannell Capital's 13F filing for Q4 2020, filed 16 Feb 2021.